Seres Therapeutics (MCRB) Amortizatization of Intangibles (2016 - 2023)
Seres Therapeutics (MCRB) has disclosed Amortizatization of Intangibles for 8 consecutive years, with $49000.0 as the latest value for Q2 2023.
- Quarterly Amortizatization of Intangibles rose 120.94% to $49000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $49000.0 through Mar 2024, up 126.06% year-over-year, with the annual reading at $236000.0 for FY2023, 134.3% up from the prior year.
- Amortizatization of Intangibles hit $49000.0 in Q2 2023 for Seres Therapeutics, down from $187000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.6 million in Q4 2021 to a low of -$851000.0 in Q1 2021.
- Historically, Amortizatization of Intangibles has averaged -$87400.0 across 5 years, with a median of -$12000.0 in 2022.
- Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 466.67% in 2019 and later crashed 17300.0% in 2021.
- Year by year, Amortizatization of Intangibles stood at $85000.0 in 2019, then tumbled by 748.24% to -$551000.0 in 2020, then surged by 390.2% to $1.6 million in 2021, then crashed by 100.75% to -$12000.0 in 2022, then skyrocketed by 508.33% to $49000.0 in 2023.
- Business Quant data shows Amortizatization of Intangibles for MCRB at $49000.0 in Q2 2023, $187000.0 in Q1 2023, and -$12000.0 in Q4 2022.